National Institute of Health

Advanced regenerative medical safety management

The Korea National Institute of Health provides support to ensure the safety of research subjects of advanced regenerative medicine clinical research and to facilitate clinical research.
Article 19 of the Act on the Safety of and Support for Advanced Regenerative Medicine and Advanced Biological Products

National Institute of Infectious Diseases

As the control tower for national infectious disease research to secure “vaccine sovereignty,” we develop measures and produce scientific evidence for the prevention of and prompt response to infectious diseases. We investigate not only emerging and variant infectious diseases but also unresolved infectious diseases, vectors, and drug resistance, and conduct diverse clinical trials.

Korea National Stem Cell Bank

Korea National Stem Cell Bank (KSCB) is a biorepository of the human pluripotent stem cell lines. To be the world`s leading class as an infrastructure supporting regenerative medicine, the bank provides the high quality stem cells and related information for regenerative medicine. The bank will compliance with standards of bioethics and safety regulations.

The GMP Manufacturing facility

The GMP Manufacturing facility which is belonged to the National Center for Stem Cell and Regerative Medicine (NCSR) was opened in 2016 to accelerate clinical research of the stem cell and regenerative medicine field. In addition to manufacturing and distribution of iPSC sources that can be used for clinical research, we support manufacture of cell therapeutics for clinical research. Recently, by starting a GMP training course for manufacture of advanced regenerative therapeutics, we expect that the GMP market will be facilitated.

National Brain Biobank of Korea (NBBK)

The National Brain Biobank of Korea is being established to collect advanced brain and human body resources with antemortem clinical data, such as brain imaging scans, and postmortem pathological information and provide them to basic and clinical researchers to activate Korea’s dementia research.